World

Trump says Putin may not want to make a deal on Ukraine

Aug 20, 2025

New York [US], August 20: U.S. President Donald Trump said on Tuesday he hoped Russia's Vladimir Putin would move forward on ending the war in Ukraine but conceded that the Kremlin leader may not want to make a deal at all, adding this would create a "rough situation" for Putin.
In an interview with the Fox News "Fox & Friends" programme, Trump said he believed Putin's course of action would become clear in the next couple of weeks. Trump again ruled out American troops on the ground in Ukraine and gave no specifics about the security guarantees he has previously said Washington could offer Kyiv under any post-war settlement.
Ukraine and its European allies have been buoyed by Trump's promise of security guarantees to help end the war during an extraordinary summit on Monday but face many unanswered questions, including how willing Russia will be to play ball.
Ukrainian President Volodymyr Zelenskiy hailed the talks at the White House as a "major step forward" towards ending Europe's deadliest conflict in 80 years and setting up a trilateral meeting with Putin and Trump in the coming weeks.
Zelenskiy was flanked by the leaders of allies including Germany, France and Britain at the summit. His warm rapport with Trump contrasted sharply with their disastrous Oval Office meeting in February.
But the path to peace remains deeply uncertain and Zelenskiy may be forced to make painful compromises to end the war, which began with Russia's full-scale invasion in February 2022. Analysts say more than 1 million people have been killed or wounded in the conflict.
Source: Fijian Broadcasting Corporation

More news

Niner Pharmaceuticals Expands into High-Purity Peptide Segment for Metabolic Health; Announces R&D for AI-Driven Ambientera Solution

Hyderabad (Telangana) [India], January 19: Niner Pharmaceuticals LLC has announced a major strategic expansion into the global high-purity peptide segment, shifting its focus beyond regulated supply chains to emphasize molecular innovation. The company aims to position these high-purity molecules as foundational tools for metabolic health, longevity, and recovery. In conjunction with this pharmaceutical expansion, the company has also disclosed that it is currently in the research and development phase for Ambientera, a new AI-driven home solution and residential operating system expected to launch next year.

Jan 19, 2026